EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipid nanoparticle-delivered mRNA vaccine encoding the MOMP of Chlamydia psittaci elicits protective immune responses in BALB/c mice

Buwei Wang, Jian Xiao, Jiewen Wang, Wanying Zhang, Yinqi Jin, Yalan Jiang, Yuqing Chen, Zhangping He, Aihua Lei, Chunxue Lu, Chuan Wang iD

Microbiology Spectrum · 02.12.2025 · 13 (12)

DOI: 10.1128/spectrum.01438-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.12.2025. Verfasst von Buwei Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathogenic Biology, School of Basic Medicine, Hengyang Medical College, University of South China, Hengyang, Hunan, China. Hauptthemen laut MEDLINE: Chlamydophila psittaci, Bacterial Outer Membrane Proteins, Bacterial Vaccines, Psittacosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chlamydia psittaci is an important pathogenic zoonotic pathogen that infects birds and can be transmitted to humans and other animals. This research focused on creating an mRNA vaccine targeting C. psittaci and assessing its immunogenic and protective effects in BALB/c mice. We carried out a trial to prepare and assess an mRNA vaccine targeting C. psittaci . This study involves an mRNA vaccine encoding the major outer membrane protein (MOMP), produced via an in vitro transcription system and encapsulated in lipid nanoparticles (LNPs). The mRNA vaccine was constructed by synthesizing non-replicating mRNA encoding MOMP. LNPs were produced and characterized for their particle morphology, size, and cytotoxicity. Histopathological analysis and indirect immunofluorescence assay of lung tissue demonstrated that mRNA vaccines effectively reduce chlamydial infection and shedding in BALB/c mice. The western blot assay confirmed the successful expression of the recombinant MOMP mediated by the target mRNA in HeLa cells. Immunization with the LNP-Opt-mRNA vaccine induced a strong immune response in mice. Mice immunized with the LNP-Opt-mRNA vaccine exhibited lower levels of C. psittaci load and decreased concentrations of interferon-γ, TNF-α, and IL-6 in the lungs compared to the PBS group. The study successfully constructed and developed the LNP-mRNA vaccine expressing the MOMP of C. psittaci . The vaccine demonstrated strong immunogenicity, inducing effective humoral and cellular immune responses that significantly decreased pulmonary C. psittaci burden in mice. These findings provide a basis for designing mRNA vaccines against C. psittaci and similar respiratory pathogens. IMPORTANCE Chlamydia psittaci is a significant threat to public health due to its zoonotic nature and capability to spread from birds to humans and other animals. It is necessary to develop an effective preventive measure. This study introduces an innovative strategy against C. psittaci using an mRNA vaccine that encodes the major outer membrane protein, demonstrating potential in eliciting robust immune responses in mice. The work emphasizes the efficacy of mRNA vaccines in inducing humoral and cellular immune responses, significantly decreasing the lung C. psittaci burden in mice and underscoring their potential against respiratory pathogens. The study indicates that lipid nanoparticle-mRNA vaccines may be a useful technique for treating and preventing C. psittaci infections, providing valuable insights for developing vaccines against other Chlamydia species and respiratory pathogens. Finally, this study provides a theoretical foundation and practical experience for the production of C. psittaci vaccines, paving the way for further exploration of mRNA vaccine platforms and co-delivery strategies to enhance immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chlamydophila psittaciBacterial Outer Membrane ProteinsBacterial VaccinesPsittacosisNanoparticlesmRNA VaccinesAnimalsMice, Inbred BALB CMiceHumansFemaleHeLa CellsRNA, MessengerLipidsVaccines, SyntheticAntibodies, BacterialCytokinesLungLiposomes

Stichwörter der Autor:innen

Chlamydia psittaciMOMPlipid nanoparticlemRNA vaccineprotective immune response

Substanzen

Bacterial Outer Membrane ProteinsBacterial VaccinesLipid NanoparticlesRNA, MessengerLipidsVaccines, SyntheticAntibodies, BacterialCytokinesmRNA VaccinesLiposomes

Autor:innen und Institutionen

  • Institute of Pathogenic Biology, School of Basic Medicine, Hengyang Medical College, University of South China, Hengyang, Hunan, China.
  • Department of Laboratory Medicine, Hengyang Medical College, The Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan, China.
  • Clinical Microbiology Laboratory, Xiangtan Central Hospital, Xiangtan, Hunan, China.

ORCID-Profile: Chuan Wang

Zitieren

APA

Wang, B., Xiao, J., Wang, J., Zhang, W., Jin, Y., Jiang, Y., Chen, Y., He, Z., Lei, A., Lu, C., & Wang, C. (2025). Lipid nanoparticle-delivered mRNA vaccine encoding the MOMP of Chlamydia psittaci elicits protective immune responses in BALB/c mice. Microbiology Spectrum, 13(12). https://doi.org/10.1128/spectrum.01438-25

Vancouver

Wang B, Xiao J, Wang J, Zhang W, Jin Y, Jiang Y, et al. Lipid nanoparticle-delivered mRNA vaccine encoding the MOMP of Chlamydia psittaci elicits protective immune responses in BALB/c mice. Microbiology Spectrum. 2025;13(12). doi:10.1128/spectrum.01438-25

BibTeX
@article{Wang2025,
  author = {Wang, Buwei and Xiao, Jian and Wang, Jiewen and Zhang, Wanying and Jin, Yinqi and Jiang, Yalan and Chen, Yuqing and He, Zhangping and Lei, Aihua and Lu, Chunxue and Wang, Chuan},
  title = {Lipid nanoparticle-delivered mRNA vaccine encoding the MOMP of Chlamydia psittaci elicits protective immune responses in BALB/c mice},
  journal = {Microbiology Spectrum},
  year = {2025},
  volume = {13},
  number = {12},
  doi = {10.1128/spectrum.01438-25}
}
Kostenlos starten →